Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PF-06755990 |
Trade Name | |
Synonyms | PF06755990|PF 06755990 |
Drug Descriptions |
PF-06755990 is cancer vaccine being developed for use in combination with the antiangiogenic therapy, Sunitinib (PMID: 29508855). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C181901 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PF-06755990 | PF-06755990 | 0 | 0 |
PF-06755990 + PF-06755992 + Sunitinib + Tremelimumab | PF-06755990 PF-06755992 Sunitinib Tremelimumab | 0 | 1 |